S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AKRO Akero Therapeutics Inc

22.03

2.37 (12.05%)

May 06 2024 - Closed

Delayed by 15 minutes

Akero Therapeutics EPS beats by $0.16

To read the full story on Seeking Alpha, click here.

Akero Therapeutics (NASDAQ:AKRO)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Akero Therapeutics Charts.

Akero Therapeutics (NASDAQ:AKRO)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Akero Therapeutics Charts.

Akero Therapeutics Inc News

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
Tuesday 30 April 2024 (7 days ago) • GlobeNewswire Inc.

Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Akero Therapeutics Announces Pricing of Public Offering of Common Stock
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

AMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on Disappointing Earnings, and Latest News
Tuesday 5 March 2024 (2 months ago) • IH Market News

Form 144 - Report of proposed sale of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

More Akero Therapeutics Inc News Articles

Greene Concepts (PK)

Movement Industries (PK)

Kraig Biocraft Laborator... (QB)

Therapeutic Solutions (PK)

TheGlobe com (PK)

Mullen Automotive

Elite Pharmaceuticals (QB)

Digital Brand Media and ... (PK)

Innerscope Hearing Techn... (PK)

Alternet Systems (PK)

International Star (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions